You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

doxorubicin

Showing 26 - 50 of 428
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Soft-tissue Sarcoma, Metastatic Soft-tissue Sarcoma Trial in Toulouse (Doxorubicin, Cyclophosphamide)

Recruiting
  • Advanced Soft-tissue Sarcoma
  • Metastatic Soft-tissue Sarcoma
  • Toulouse, France
    Institut Claudius Reagaud-IUCT Oncopôle
Sep 27, 2021

Soft Tissue Sarcoma Adult Trial in Italy (Cyclophosphamide, Doxorubicin)

Recruiting
  • Soft Tissue Sarcoma Adult
  • Bologna, BO, Italy
  • +12 more
Mar 31, 2022

Soft Tissue Sarcoma Trial in Bergen, Oslo (Ifosfamide, Doxorubicin)

Recruiting
  • Soft Tissue Sarcoma
  • Bergen, Norway
  • +1 more
Sep 10, 2021

Metastatic Kidney Medullary Carcinoma, Metastatic Renal Cell Carcinoma, SMARCB1 Negative Trial in Houston (Doxorubicin,

Recruiting
  • Metastatic Kidney Medullary Carcinoma
  • +4 more
  • Doxorubicin
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 14, 2021

Cervical Cancer Trial in Leuven (Atezolizumab, Doxorubicin)

Active, not recruiting
  • Cervical Cancer
  • Leuven, Belgium
    UZLeuven
Jan 26, 2021

HER2-negative Breast Cancer, Advanced Solid Tumor Trial in Singapore (ADG106, Doxorubicin, Cyclophosphamide)

Recruiting
  • HER2-negative Breast Cancer
  • Advanced Solid Tumor
  • Singapore, Singapore
    National University Hospital
Jun 9, 2022

Metastatic Adult Soft Tissue Sarcoma, Recurrent Adult Soft Tissue Sarcoma Trial in Hannover (Durvalumab and Tremelimumab,

Active, not recruiting
  • Metastatic Adult Soft Tissue Sarcoma
  • Recurrent Adult Soft Tissue Sarcoma
  • Durvalumab and Tremelimumab
  • Doxorubicin
  • Hannover, Germany
    Medizinische Hochschule Hannover
Jun 1, 2021

Glioblastoma Trial in Saint Louis (device, drug, other)

Completed
  • Glioblastoma
  • MRI-guided Laser Heat Ablation (MLA)
  • +3 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Aug 26, 2021

Lymphoproliferative Disorder, HHV-8, Malignancy Trial run by the National Cancer Institute (NCI) (Etoposide, Interferon-alpha,

Active, not recruiting
  • Lymphoproliferative Disorder
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022

Pharmacogenetic Study in Hepatocellular Carcinoma Patients.

Recruiting
  • Hepatocellular Carcinoma
  • Cairo, Egypt
    Ain Shams University hepatoma group, EL Demerdash Hospital, Cair
Mar 12, 2022

DLBCL Trial in Cleveland (Loncastuximab tesirine, Prednisone, Rituximab)

Withdrawn
  • Diffuse Large B-Cell Lymphoma
  • Loncastuximab tesirine
  • +5 more
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center
Mar 15, 2022

Lymphoma Trial in China (Brentuximab Vedotin, Cyclophosphamide, Doxorubicin)

Not yet recruiting
  • Lymphoma
  • Brentuximab Vedotin
  • +3 more
  • Beijing, China
  • +15 more
Jan 4, 2023

Diffuse Large B Cell Lymphoma Trial (Rituximab, Cyclophosphamide, Doxorubicin)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • (no location specified)
Apr 24, 2022

Lymphoma, Large B-Cell, Diffuse (DLBCL) Trial in Jerusalem, Seoul, Warszawa (Zilovertamab Vedotin, Cyclophosphamide,

Recruiting
  • Lymphoma, Large B-Cell, Diffuse (DLBCL)
  • Zilovertamab Vedotin
  • +6 more
  • Jerusalem, Israel
  • +1 more
Jul 25, 2022

Lymphoma Trial in Worldwide (Glofitamab, Tocilizumab, Doxorubicin)

Recruiting
  • Lymphoma
  • Duarte, California
  • +13 more
Aug 18, 2022

Neuroblastoma, Pediatric Cancer Trial in New York (Cyclophosphamide, Topotecan, Vincristine)

Recruiting
  • Neuroblastoma
  • Pediatric Cancer
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Aug 11, 2022

DLBCL Trial in Cleveland (ME-401, Rituximab, Cyclophosphamide)

Recruiting
  • Diffuse Large B-Cell Lymphoma
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer institute, Case Comprehensive Ca
Feb 2, 2022

Breast Tumors Trial in San Sebastián de los Reyes (Docetaxel, 5-fluorouracil, Doxorubicin)

Completed
Has Results
  • Breast Neoplasms
  • San Sebastián de los Reyes, Madrid, Spain
    Spanish Breast Cancer Research Group
Nov 10, 2020

Breast Cancer Trial in Boston, Hooksett (Doxorubicin, Cyclophosphamide, Paclitaxel)

Completed
Has Results
  • Breast Cancer
  • Doxorubicin
  • +3 more
  • Boston, Massachusetts
  • +3 more
Apr 26, 2021

Breast Cancer Trial in Houston (Paclitaxel, Eribulin, 5-Fluorouracil)

Completed
Has Results
  • Breast Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Aug 26, 2021

Breast Cancer, Triple Negative Breast Cancer Trial in United States (Carboplatin, Paclitaxel, Doxorubicin)

Active, not recruiting
  • Breast Cancer
  • Triple Negative Breast Cancer
  • Rockford, Illinois
  • +5 more
Mar 29, 2021

Glioblastoma (GBM), DIPG, Brainstem Glioma, Pediatric Trial in Florence (Doxorubicin)

Terminated
  • Glioblastoma (GBM)
  • +7 more
  • Doxorubicin
  • Florence, Italy
    Meyer Children's Hospital
Feb 4, 2021

Breast Cancer Trial in Pittsburgh (Bevacizumab, Doxorubicin, Cyclophosphamide)

Completed
Has Results
  • Breast Cancer
  • Pittsburgh, Pennsylvania
    NSABP Foundation, Inc.
Apr 9, 2021

Lymphoma, T-Cell, Peripheral Trial in Czechia (Adcetris 50 MG Injection, Endoxan, Doxorubicin)

Not yet recruiting
  • Lymphoma, T-Cell, Peripheral
  • Adcetris 50 MG Injection
  • +4 more
  • Brno, Czechia
  • +6 more
Aug 26, 2021

High-risk Large B-cell Lymphoma (LBCL) Trial (Axicabtagene Ciloleucel, Cyclophosphamide, Fludarabine)

Not yet recruiting
  • High-risk Large B-cell Lymphoma (LBCL)
  • Axicabtagene Ciloleucel
  • +7 more
  • (no location specified)
Dec 13, 2022